Prelude Therapeutics Incorporated

PRLD · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$47,532$25,752$40,269$12,474
Short-Term Investments$7,425$47,464$58,805$121,140
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,373$0$3,329$2,281
Total Curr. Assets$58,330$76,876$102,403$135,895
Property Plant & Equip (Net)$33,080$33,888$34,703$35,466
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$3,235$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$110$4,154$4,154$4,154
Total NC Assets$36,425$38,042$38,857$39,620
Other Assets$0$0$0$0
Total Assets$94,755$114,918$141,260$175,515
Liabilities
Payables$2,533$4,962$5,831$7,732
Short-Term Debt$2,727$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,445$861$4,553$9,793
Total Curr. Liab.$18,190$20,908$19,787$25,641
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$2,904$2,966$3,028$3,090
Total NC Liab.$18,031$18,172$18,295$18,415
Other Liabilities$0$0$0$0
Cap. Leases$0$17,917$17,920$18,025
Total Liabilities$36,221$39,080$38,082$44,056
Equity
Pref Stock$0$0$0$0
Common Stock$5$5$5$5
Retained Earnings-$666,604-$646,879-$615,648-$583,563
AOCI$2-$1$12$35
Other Equity$0-$0$0$0
Total Equity$58,534$75,838$103,178$131,459
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$94,755$114,918$141,260$175,515
Net Debt-$44,805-$25,752-$40,269-$12,474
Prelude Therapeutics Incorporated (PRLD) Financial Statements & Key Stats | AlphaPilot